← Open Payments lookup

CHRISTINA BERMEA: Open Payments

NPI 1417456393 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,204 in 40 payments from 9 companies in 2025. Trend: 2023 $637 · 2024 $774 · 2025 $1,204

Food & beverage: $1,204
CompanyPaymentsAmount
ABBVIE INC.15$347
E.R. Squibb & Sons, L.L.C.10$277
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$194
Teva Pharmaceuticals USA, Inc.4$160
Axsome Therapeutics, Inc.1$121
Alkermes, Inc.2$43
Vanda Pharmaceuticals Inc.1$24
Neurocrine BioSciences, Inc.1$23
Otsuka America Pharmaceutical, Inc.1$14

Products named: VRAYLAR, COBENFY, CAPLYTA, UZEDY, Auvelity, AUSTEDO XR, LYBALVI, FANAPT.

Industry payments across TX — which companies pay providers there.